Using genetic networks to prevent HIV and other infections in people who inject drugs
Leveraging HCV Phylogenetic Networks to Prevent HIV and Other Blood Borne Infections Among People Who Inject Drugs
['FUNDING_OTHER'] · ALBERT EINSTEIN COLLEGE OF MEDICINE · NIH-10238557
This study is looking at how to stop the spread of HIV and hepatitis C among people who use injectable drugs in Kenya by figuring out who is most connected in the networks of infection, so we can create better health programs to help those at risk.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ALBERT EINSTEIN COLLEGE OF MEDICINE (nih funded) |
| Locations | 1 site (BRONX, UNITED STATES) |
| Trial ID | NIH-10238557 on ClinicalTrials.gov |
What this research studies
This research investigates how to prevent HIV and other blood-borne infections among people who inject drugs (PWID) by analyzing the genetic relationships of the hepatitis C virus (HCV). The study will identify key individuals within transmission networks in Kenya who are most central to the spread of these infections. By understanding their demographic, behavioral, and geographic risk factors, the research aims to model effective public health interventions that can significantly reduce the transmission of HIV and other infections. This approach focuses on marginalized populations, particularly in low- and middle-income countries where healthcare resources may be limited.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs, particularly those living in or connected to communities in Kenya.
Not a fit: Patients who do not inject drugs or those living outside the targeted geographic areas may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted interventions that significantly reduce the incidence of HIV and other blood-borne infections among PWID.
How similar studies have performed: Other research has shown success in using genetic analysis to inform public health strategies, making this approach both innovative and grounded in prior findings.
Where this research is happening
BRONX, UNITED STATES
- ALBERT EINSTEIN COLLEGE OF MEDICINE — BRONX, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: AKIYAMA, MATTHEW — ALBERT EINSTEIN COLLEGE OF MEDICINE
- Study coordinator: AKIYAMA, MATTHEW
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.